A randomized trial at MD Anderson Cancer Center found that personalized navigation support raised BRCA genetic testing uptake ...

The National Comprehensive Cancer Network recommends germline genetic testing for patients with prostate cancer and high-risk features or a suggestive family history. In 2024, the University of ...

AI-based research identifies ZNF268 as a potential marker of prostate cancer progression, raising hopes for more accurate ...

Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. "Our ...

Understanding your mother's cancer history is crucial in assessing prostate cancer risk. Learn how genetic factors influence ...

Findings from a study exploring how AI-driven NCCN guideline interpretation can optimize genetic testing and reduce clinician burden in prostate cancer. Keeping pace with rapid updates to NCCN ...

LOS ANGELES--(BUSINESS WIRE)--MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new ...

LOS ANGELES, February 24, 2026--(BUSINESS WIRE)--MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of ...

"Is cancer genetic testing something that is passed down to family members?" Have you ever felt anxious about that?By reading ...

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...

Please provide your email address to receive an email when new articles are posted on . Findings, which were presented at ASCO Annual Meeting, showed the model demonstrated 100% accuracy in 2025 in ...